StonvexLoading…
StonvexStonvexStonvexCore line items from PEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $1.40B | $1.19B | $1.06B | $270.95M |
Operating Income | $189.25M | $9.28M | $73.55M | $13.30M |
Net Income | $177.69M | $14.01M | $90.95M | $9.21M |
EPS (Diluted) | $4.52 | $0.36 | $2.32 | $0.23 |
Total Assets | $1.83B | $1.53B | $1.56B | Not available |
Total Liabilities | $398.92M | $382.25M | $377.36M | Not available |
Cash & Equivalents | $186.90M | $324.40M | $167.49M | Not available |
Free Cash Flow OCF − CapEx | $174.93M | $147.30M | $82.12M | Not available |
Shares Outstanding | 39.23M | 38.49M | 38.68M | 39.22M |